Molina Healthcare Q1 EPS rises 5% to $5.45; full-year guidance reaffirmed
Molina Healthcare reported first-quarter 2025 GAAP diluted EPS of $5.45, up 5% from $5.17 a year earlier, and adjusted EPS of $6.08, up 6% from $5.73. Total revenue rose to $11.1 billion from $9.9 billion, but GAAP net income was $298 million, down from $301 million, and the medical care ratio rose to 89.2% from 88.5%. The company reaffirmed its full-year 2025 guidance of approximately $42 billion in premium revenue and adjusted EPS of at least $24.50.
Key points
- GAAP diluted EPS $5.45 vs. $5.17 a year earlier (up 5%); adjusted diluted EPS $6.08 vs. $5.73 (up 6%)
- Total revenue $11.1 billion vs. $9.9 billion; premium revenue $10.6 billion, up 12% year over year
- Medical care ratio 89.2% vs. 88.5%; GAAP net income $298 million vs. $301 million
- 2025 guidance reaffirmed: premium revenue about $42 billion and adjusted EPS at least $24.50; GAAP EPS at least $22.32
The filing
Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 23, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.